Wall Street Experts
ver. ZuMIgo(08/25)
Ironwood Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 378
EBIT TTM (mln): 104
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
Rok finansowy |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
3 |
10 |
22 |
36 |
44 |
66 |
150 |
23 |
76 |
150 |
274 |
298 |
347 |
428 |
390 |
414 |
411 |
443 |
351 |
Przychód Δ r/r |
0.0% |
233.2% |
112.3% |
62.5% |
21.5% |
50.2% |
128.1% |
-84.8% |
234.1% |
95.7% |
83.2% |
8.9% |
16.2% |
23.6% |
-9.1% |
6.2% |
-0.8% |
7.8% |
-20.6% |
Marża brutto |
0.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
99.4% |
68.5% |
66.5% |
100.0% |
99.3% |
93.5% |
90.6% |
94.4% |
99.2% |
99.6% |
99.7% |
99.6% |
100.0% |
EBIT (mln) |
-40 |
-58 |
-56 |
-73 |
-61 |
-66 |
-73 |
-252 |
-169 |
-102 |
-52 |
-77 |
-239 |
120 |
143 |
232 |
250 |
209 |
95 |
EBIT Δ r/r |
0.0% |
45.5% |
-2.9% |
30.1% |
-16.5% |
8.8% |
10.0% |
246.3% |
-32.8% |
-39.7% |
-49.2% |
49.2% |
208.7% |
-150.3% |
19.0% |
62.5% |
7.8% |
-16.5% |
-54.6% |
EBIT (%) |
-1261.0% |
-550.6% |
-251.7% |
-201.6% |
-138.6% |
-100.4% |
-48.4% |
-1101.4% |
-221.6% |
-68.3% |
-18.9% |
-25.9% |
-68.9% |
28.0% |
36.7% |
56.1% |
61.0% |
47.2% |
27.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
21 |
21 |
31 |
38 |
34 |
35 |
37 |
29 |
31 |
8 |
22 |
-33 |
EBITDA (mln) |
-36 |
-52 |
-51 |
-67 |
-62 |
-56 |
-73 |
-252 |
-169 |
-84 |
-41 |
-102 |
-94 |
120 |
160 |
233 |
260 |
211 |
95 |
EBITDA(%) |
-1140.2% |
-494.7% |
-229.3% |
-186.4% |
-141.8% |
-84.5% |
-48.4% |
-1101.4% |
-221.6% |
-56.5% |
-14.9% |
-34.4% |
-27.1% |
28.1% |
41.0% |
56.3% |
63.3% |
47.6% |
27.0% |
Podatek (mln) |
0 |
-0 |
-1 |
-0 |
-3 |
0 |
-11 |
-12 |
9 |
19 |
38 |
34 |
-6 |
74 |
3 |
-328 |
77 |
83 |
-64 |
Zysk Netto (mln) |
-37 |
-53 |
-54 |
-71 |
-53 |
-65 |
-73 |
-273 |
-190 |
-143 |
-82 |
-117 |
-282 |
-15 |
106 |
528 |
175 |
-1,002 |
131 |
Zysk netto Δ r/r |
0.0% |
41.9% |
2.1% |
32.1% |
-25.6% |
22.4% |
12.0% |
275.6% |
-30.5% |
-24.8% |
-42.7% |
43.1% |
141.5% |
-94.6% |
-793.3% |
397.7% |
-66.9% |
-672.5% |
-113.0% |
Zysk netto (%) |
-1184.1% |
-504.1% |
-242.5% |
-197.2% |
-120.8% |
-98.5% |
-48.3% |
-1192.3% |
-248.1% |
-95.4% |
-29.8% |
-39.2% |
-81.5% |
-3.6% |
27.3% |
127.7% |
42.6% |
-226.4% |
37.2% |
EPS |
-0.39 |
-7.41 |
-7.82 |
-10.0 |
-0.59 |
-0.65 |
-0.68 |
-2.35 |
-1.39 |
-1.0 |
-0.56 |
-0.78 |
-1.85 |
-0.0982 |
0.67 |
3.26 |
1.13 |
-6.45 |
0.82 |
EPS (rozwodnione) |
-0.39 |
-0.7 |
-7.82 |
-0.94 |
-0.59 |
-0.65 |
-0.68 |
-2.35 |
-1.39 |
-1.0 |
-0.56 |
-0.78 |
-1.85 |
-0.0982 |
0.66 |
3.21 |
0.94 |
-6.45 |
0.82 |
Ilośc akcji (mln) |
95 |
7 |
7 |
7 |
90 |
100 |
106 |
116 |
137 |
142 |
145 |
148 |
153 |
156 |
159 |
162 |
154 |
155 |
160 |
Ważona ilośc akcji (mln) |
95 |
76 |
7 |
76 |
90 |
100 |
106 |
116 |
137 |
142 |
146 |
149 |
153 |
156 |
161 |
164 |
186 |
155 |
160 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |